Helping to Bring Improved and Novel Therapies to the Right Patient Population Faster
Case study: Combination matrix to determine Bliss independence synergy scores
November 19, 2021: A new case study is [...]
Oncolines opens a new screening lab
Oncolines is expanding its lab capacity with [...]
NTRC Precision Medicine Services is now Oncolines
As an independent company, Oncolines will now be singularly focused on [...]
- Combination matrix to determine Bliss independence synergy scoresNTRC Oncolines2021-11-17T16:21:49+01:00
- Case study – Pharmacological models to assess the role of tryptophan-metabolizing enzymes in cancerNTRC Oncolines2021-10-21T11:38:04+02:00
- Case study – Synergistic interaction of olaparib and cisplatinNTRC Oncolines2021-10-21T11:38:40+02:00
PREMIUM BENEFITS OF ONCOLINES PRECISION MEDICINE SERVICES: Cell-Based Assays, Drug Combinations, High-Throughput Screening
Integration of cancer biology and big data analysis
Identification of patient selection markers
Side-by-side comparison with known anti-cancer agents
Discovery of targeted and novel synergistic drug combinations
Science-driven technology platforms
Short turnaround times
